Stock-Based Compensation: What It Costs You

The basic mechanic

When a company grants stock to employees — whether as restricted stock units, stock options, or performance shares — it creates new shares. Those new shares go to the employees. Your slice of the company shrinks. That's dilution, and it happens whether or not the company spends a single dollar of cash.

Think of it this way. If a company has 100 shares outstanding and grants 5 new shares to its engineering team, the engineers now own 4.8% of the company and every existing shareholder owns 4.8% less of what they held before. The company didn't write a check. You just paid the compensation bill by having your stake reduced.

This is why SBC is so easy to ignore. There's no wire transfer, no invoice, no line in the operating budget that makes a CFO wince. The cost is invisible in the cash account and diffuse across all shareholders. That invisibility is exactly what makes it dangerous in a portfolio context — it's a real economic transfer that the standard financial presentation is designed to de-emphasize.

Why the headline numbers hide it

Under GAAP, SBC does flow through the income statement as an expense. That part is correct. A company that grants $200M in stock compensation will show $200M less in operating income than it would without those grants. The problem arrives on the cash flow statement.

Because SBC requires no cash outlay, accountants add it back in the operating activities section — the same section where depreciation gets added back. This is mechanically correct: the purpose of operating cash flow is to strip out non-cash items and show you the underlying cash generation of the business. But here's where the exploitation happens. Companies, and most of the sell-side analysts covering them, use "operating cash flow minus CapEx" as their definition of free cash flow. Since SBC was already added back in operating cash flow, it never gets subtracted again. It disappears.

The result is a "free cash flow" figure that overstates what shareholders actually capture. Consider a worked example. A software company reports $320M in operating cash flow and $40M in capital expenditures. Headline FCF: $280M. With a $12B market cap, that's a 2.3% FCF yield — not screaming cheap, but defensible for a growth company. Now look at the cash flow statement more carefully. There's $110M in stock-based compensation buried in the operating activities section. Subtract that, and true FCF is $170M — a 1.4% yield. The company is pricing in considerably more future growth than the headline number suggests.

This isn't a hypothetical. Salesforce (CRM) ran SBC above $1.5B annually for years while reporting positive free cash flow that looked appealing on a headline basis. Meta's SBC peaked at $9.2B in 2022, the same year the company heavily promoted its operating efficiency story. Snap has routinely reported adjusted EBITDA in positive territory while running SBC at 30–40% of revenue, meaning the "profitable" headline was built almost entirely on the exclusion.

The non-GAAP add-back was invented to solve a real problem: early-stage companies with heavy equity programs looked artificially unprofitable compared to mature peers who paid cash. The logic was sound. Then investor relations teams realized that "adjusted EBITDA" with SBC stripped out made every growth company look like it was gushing cash. The tool got weaponized.

The three numbers that matter

No single ratio tells you whether a company's SBC is a problem. But three calibration points, read together, will tell you whether you need to dig deeper before trusting the free cash flow story.

• SBC as a percentage of revenue. Above 10% is where it starts visibly costing shareholders in a sector-adjusted way. Most established technology companies run 3–7%. Early-stage SaaS companies sometimes run 12–18% and that can be acceptable — temporarily. Above 15% in a company with more than $1B in revenue is almost always a red flag. You can find SBC in the operating activities section of the cash flow statement and revenue on the income statement; divide and track the ratio over four to eight quarters.
• SBC as a percentage of reported free cash flow. When SBC exceeds 25% of what the company calls free cash flow, the FCF story is mostly fiction — or at minimum, highly dependent on a narrative about future dilution decelerating. Above 50% means the company is not generating real cash for shareholders at all; it is generating the appearance of cash by handing out paper. This ratio is the fastest way to identify companies whose valuation models are built on a number that doesn't mean what investors think it means.
• Annual diluted share count growth. Pull the diluted weighted average shares outstanding from the EPS section of the income statement and compare it year-over-year. Above 3% annually is value-destructive at normal equity valuations: if the business grows earnings 10% but you're holding a claim that shrinks 3% annually, your real return is closer to 7%. Above 5% is typically unsustainable without exceptional revenue growth. Below 1% — especially if it's flat or declining — means the company's buybacks are actually keeping pace.

These aren't rules. They are calibration points. A company running 12% SBC/revenue with a diluted share count that has been flat for three years and a revenue growth rate of 40% is a different animal than a company running 12% SBC/revenue with a 4% annual share count increase and 8% revenue growth. The ratios tell you where to look. The trend tells you what to think.

Use our Share Dilution Calculator to model the EPS impact of stock-based compensation for any US-listed ticker.

How to adjust your own valuation

The mechanical fix is simple. When you build your own FCF calculation, start with operating cash flow from the cash flow statement, subtract CapEx, then subtract SBC. That's it. This gives you FCF that reflects the actual economic cost of running the business including its equity compensation program.

Finding the SBC line is easy once you know where to look. In every 10-K and 10-Q, the cash flow statement begins with net income and then lists adjustments for non-cash items. SBC is always in that list — usually within the first five line items — labeled "stock-based compensation" or "share-based compensation expense." The number is already gross. You subtract the whole thing.

Here's what the adjustment does to a real-looking example. Suppose a company with a $3.5B market cap reports $210M in operating cash flow and $55M in CapEx. Reported FCF is $155M. Headline FCF yield: 4.4%. Respectable for a tech company in a normal rate environment — not screaming cheap, but not obviously expensive either. Now pull the SBC line: $72M. Adjusted FCF drops to $83M. Adjusted FCF yield: 2.4%. That same company just went from "reasonably priced" to "priced for continued strong growth" — and the only thing that changed is how you treated a number that was always there.

This adjustment has the most force when comparing two companies. If you're evaluating two SaaS businesses on FCF yield and one has 8% SBC/revenue and one has 22%, the comparison on headline FCF is misleading by design. Once you adjust both, the valuation gap usually looks very different.

For FCF multiples rather than yields, the same adjustment applies in reverse: use your adjusted FCF in the denominator. A stock trading at 25x adjusted FCF is a very different investment than a stock trading at 25x reported FCF where SBC represents 30% of that number.

When SBC isn't the problem

High SBC is not automatically disqualifying. The question is whether it's on a trajectory that makes sense for the business. Early-stage companies — especially those growing revenue at 30%+ annually — often need to compete for engineering and product talent against larger, more cash-rich employers. Equity is how they do it. A company with $300M in revenue running $45M in SBC (15%) might be completely rational if that talent is the reason the revenue is growing 40% and the ratio is shrinking every year.

What you want to see as a company scales: SBC growing in dollar terms but shrinking as a percentage of revenue. That's the sign that the equity program is a tool being used to build the business, not a treadmill that shareholders are funding indefinitely. If SBC was 14% of revenue three years ago and is 9% today, that's a reasonable arc even if the absolute dollar figure doubled. If SBC was 14% three years ago and is 16% today despite revenue growing significantly, the company is using more equity to generate each dollar of revenue — not less. That's the warning sign.

The same logic applies to diluted share counts. A high-growth company whose share count grew 6% three years ago, 4% two years ago, and 2% last year is heading in the right direction. One whose share count has been growing 4–5% every year for five years, with no sign of deceleration, is telling you something different about capital discipline.

The structure problem: not just how much, but who gets it

The aggregate SBC number tells you the cost. The proxy statement tells you where it went. These are two different pieces of information, and they raise different questions.

A company where the CEO receives 40% or more of total equity grants has a concentration problem. It means the equity program is primarily a compensation vehicle for a small number of executives rather than a broad-based retention tool for the employees actually building the product. That matters for incentive alignment: executives who receive massive grants that vest over four years have meaningful incentives to manage the stock price over that window, not necessarily the long-run fundamentals. It also matters for cultural reasons — companies with broad equity distribution across engineers, salespeople, and operations tend to have meaningfully different retention and output characteristics than companies where grants flow almost entirely to the C-suite.

The proxy statement (filed as DEF 14A with the SEC) discloses every named executive officer's equity grants in a "Grants of Plan-Based Awards" table. It also includes a "Beneficial Ownership" table that shows how much stock each executive actually holds. Read both. A CEO who receives $40M in annual grants but has sold shares aggressively since vesting is demonstrating a different level of conviction than one who has retained most of their holdings. The proxy statement guide covers how to find and read both tables.

Broad-based equity programs — where grants reach product managers, engineers, and customer success teams — are genuinely different from executive-heavy programs. The former is a retention and alignment tool. The latter is mostly a compensation negotiation. Both cost shareholders the same amount per dollar of SBC, but they're solving different problems, and the incentive dynamics downstream are not the same.